Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Volume: 85

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. Department of Neurology, Medical University of Vienna, Waehringer Guertel -, Vienna , Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria. Department of Neurology, Medical University of Vienna, Waehringer Guertel -, Vienna , Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria. Electronic address: gabriel.bsteh@meduniwien.ac.at.

Abstract summary 

Olfactory threshold (OT) is a marker of short-term inflammatory activity in multiple sclerosis (MS).To investigate whether OT predicts long-term MS clinical disease course.This was a 6-year prospective longitudinal study on MS patients at the MS clinic Innsbruck. Clinical visits assessing the occurrence of relapses, Expanded Disability Status Scale (EDSS) scores, and disease-modifying treatment (DMT), were conducted biannually. OT testing was performed at baseline (BL), year 1 (Y1), year 2 (Y2) and year 6 (Y6), using the threshold subscore of the "Sniffin' Sticks" test. Cognitive function was assessed by the Symbol Digit Modalities Test.Of 139 MS patients, 92 were eligible for Y6 follow-up. 68% experienced relapses, 53% EDSS worsening, 29% progression independent of relapse activity (PIRA) and 41% cognitive deterioration. OT scores were lower at BL, Y1 and Y2 in patients requiring DMT escalation. In multivariable analysis, higher OT scores at BL, Y1, Y2 and Y6 were associated with lower risk of relapse (hazard ratio, HR: 0.65-0.92) and EDSS worsening (HR: 0.86-0.89), while no associations were found for PIRA and cognitive deterioration.OT is a potential surrogate marker for long-term inflammatory disease activity and DMT failure in MS.

Authors & Co-authors:  Berek Hegen Auer Barket Di Pauli Hocher Krajnc Zinganell Deisenhammer Berger Bsteh

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  11
Identifiers
Doi : 10.1016/j.msard.2024.105545
SSN : 2211-0356
Study Population
Male,Female
Mesh Terms
Other Terms
Biomarker;Disease activity;Multiple sclerosis;Olfactory function;Relapse
Study Design
Longitudinal Study
Study Approach
Country of Study
Publication Country
Netherlands